Literature DB >> 10329408

Hyperglycemia increases vascular adrenomedullin expression.

M Hayashi1, T Shimosawa, T Fujita.   

Abstract

We have reported that plasma adrenomedullin (AM) in hyperglycemic patients was significantly increased compared with normal volunteers. In this report we examined the effects of hyperglycemia on AM expression in the vasculature, the main site of AM production. AM mRNA level in the aorta was higher in the diabetic rats than in the control rats. AM mRNA level and protein kinase C (PKC) activity in cultured vascular smooth muscle cells (VSMC) increased as the glucose concentration in the medium changed from 100mg/dl to 450mg/dl. PKC inhibitors blocked this increase of AM mRNA. Similar osmotic change with mannitol had no effect on AM expression. We conclude that (1) hyperglycemia increases vascular AM expression through PKC-dependent pathway, and (2) the elevated plasma AM in hyperglycemic patients originates from the glucose induced vascular AM expression. We propose the possible role of AM in the pathogenesis of diabetic vascular complications. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329408     DOI: 10.1006/bbrc.1999.0664

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Adrenomedullin: possible predictor of insulin resistance in women with polycystic ovary syndrome.

Authors:  I Sahin; O Celik; N Celik; L Keskin; A Dogru; I Dogru; M Yürekli; S Yologlu
Journal:  J Endocrinol Invest       Date:  2011-07-25       Impact factor: 4.256

Review 2.  Adrenomedullin and diabetes.

Authors:  Hoi Kin Wong; Fai Tang; Tsang Tommy Cheung; Bernard Man Yung Cheung
Journal:  World J Diabetes       Date:  2014-06-15

3.  Plasma adrenomedullin level in Egyptian children and adolescents with type 1 diabetes mellitus: relationship to microvascular complications.

Authors:  Safinaz A El-Habashy; Randa M Matter; Eman S El-Hadidi; Hala R Afifi
Journal:  Diabetol Metab Syndr       Date:  2010-02-10       Impact factor: 3.320

4.  Inhibition of the adrenomedullin/nitric oxide signaling pathway in early diabetic retinopathy.

Authors:  Jan J Blom; Thomas J Giove; Tara L Favazza; James D Akula; William D Eldred
Journal:  J Ocul Biol Dis Infor       Date:  2012-01-12

5.  The role of adrenomedullin in the renal NADPH oxidase and (pro)renin in diabetic mice.

Authors:  Michio Hayashi; Akihiro Tojo; Tatsuo Shimosawa; Toshiro Fujita
Journal:  J Diabetes Res       Date:  2013-07-15       Impact factor: 4.011

6.  Adrenomedullin has a cytoprotective role against endoplasmic reticulum stress for pancreatic β-cells in autocrine and paracrine manners.

Authors:  Risa Suetomi; Yasuharu Ohta; Masaru Akiyama; Takuro Matsumura; Akihiko Taguchi; Kaoru Yamamoto; Takashi Kamatani; Yukio Tanizawa
Journal:  J Diabetes Investig       Date:  2020-03-10       Impact factor: 4.232

7.  Adrenomedullin in peritoneal effluent expressed by peritoneal mesothelial cells.

Authors:  Rika Kono; Koichi Kanozawa; Tatsuo Shimosawa; Yousuke Tayama; Akihiko Matsuda; Hajime Hasegawa; Tetsuya Mitarai
Journal:  Clin Exp Nephrol       Date:  2013-04-06       Impact factor: 2.801

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.